Literature DB >> 15713128

Compliance with prophylactic platelet transfusion trigger in haematological patients.

J C J Eikenboom1, R van Wordragen, A Brand.   

Abstract

The aim of prophylactic platelet transfusions in haemato-oncologic patients with thrombocytopenia is to prevent bleeding. Currently, a platelet transfusion trigger of 10 x 10(9) L(- 1) is considered to be safe. Transfusion compliance with this trigger can save costs. To investigate the compliance with this trigger of 10 x 10(9) L(- 1), we have evaluated 1447 platelet transfusions given during a period of 1 year to haematological patients. In half of the transfusions, there had been compliance with the trigger of 10 x 10(9) L(- 1). About three-quarters of all platelet transfusions were given at platelet counts < or =20 x 10(9) L(- 1). Transfusions at levels >20 x 10(9) L(- 1) were usually performed because of bleeding, scheduled interventions or concurrent anticoagulant therapy. We conclude that compliance with the prophylactic platelet transfusion trigger of 10 x 10(9) L(- 1) was about 50%; however, deviation from the trigger was partly explained by risk factors that justify a higher transfusion trigger.

Entities:  

Mesh:

Year:  2005        PMID: 15713128     DOI: 10.1111/j.1365-3148.2005.00547.x

Source DB:  PubMed          Journal:  Transfus Med        ISSN: 0958-7578            Impact factor:   2.019


  4 in total

1.  An audit of platelet transfusion indications in acute leukaemia patients: six-year experience at an Academic Centre.

Authors:  José C Jaime-Pérez; Gerardo García-Salas; Grecia A Turrubiates-Hernández; Dalila M Alvarado-Navarro; Luis J Marfil-Rivera; David Gómez-Almaguer
Journal:  Blood Transfus       Date:  2020-11-03       Impact factor: 3.443

2.  Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort.

Authors:  Damon E Houghton; Nigel S Key; Neil A Zakai; Jeffrey P Laux; Thomas C Shea; Stephan Moll
Journal:  Leuk Lymphoma       Date:  2017-04-09

3.  Younger age and previous exposure to radiation therapy are correlated with the severity of chemotherapy-induced thrombocytopenia.

Authors:  Sergo Mkhitaryan; Samvel Danielyan; Lilit Sargsyan; Lusine Hakobyan; Samvel Iskanyan; Samvel Bardakchyan; Ruzanna Papyan; Jemma Arakelyan; Karmen Sahakyan; Tatevik Avagyan; Armen Tananyan; Armen Muradyan; Gevorg Tamamyan
Journal:  Ecancermedicalscience       Date:  2019-02-26

4.  The TREATT Trial (TRial to EvaluAte Tranexamic acid therapy in Thrombocytopenia): safety and efficacy of tranexamic acid in patients with haematological malignancies with severe thrombocytopenia: study protocol for a double-blind randomised controlled trial.

Authors:  Lise J Estcourt; Zoe McQuilten; Gillian Powter; Claire Dyer; Eleanor Curnow; Erica M Wood; Simon J Stanworth
Journal:  Trials       Date:  2019-10-15       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.